ALNYLAM PHARMACEUTICALS, INC. (32) | Business Finance (6)

Browse by Subcategory

Recent Contracts

Amendment No. 1 to Co-Development Agreement between the Registrant and BXLS V Bodyguard PCP L.P. and BXLS Family Investment Partnership V ESC L.P. dated November 23, 2021 (Filed With SEC on February 10, 2022)
Purchase and Sale Agreement dated April 10, 2020 between BX Bodyguard Royalties L.P. and the Registrant (Filed With SEC on August 6, 2020)
Description of Capital Stock (Filed With SEC on February 13, 2020)
Underwriting Agreement, dated January 14, 2019, between Alnylam Pharmaceuticals, Inc. and Barclays Capital Inc (Filed With SEC on January 15, 2019)
Stock Purchase Agreement dated as of April 8, 2019 by and between the Registrant and Regeneron Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
Amended and Restated 2004 Employee Stock Purchase Plan, as amended (Filed With SEC on May 2, 2019)